Need professional-grade analysis? Visit stockanalysis.com
$41.85B
N/A
N/A
10.00%
Price Chart
Risk-Adjusted Performance
Also Listed On
GALDERMA GROUP AG (GALDY) Price Performance
GALDERMA GROUP AG (GALDY) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $36.42, up 2.07% from the previous close.
Over the past year, GALDY has traded between a low of $18.36 and a high of $42.27. The stock has gained 74.6% over this period. It is currently 13.8% below its 52-week high.
GALDERMA GROUP AG has a market capitalization of $41.85B and a dividend yield of 10.00%.
About GALDERMA GROUP AG
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Company Info
- Sector
- Healthcare
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $5.24B
- EBITDA
- $1.13B
- Profit Margin
- 11.70%
- EPS (TTM)
- 0.52
- Book Value
- 34.74
Technical Indicators
- 52 Week High
- $42.93
- 52 Week Low
- $17.25
- 50 Day MA
- $38.46
- 200 Day MA
- $35.86
- Beta
- N/A
Valuation
- Trailing P/E
- 68.62
- Forward P/E
- 5.29
- Price/Sales
- 7.98
- Price/Book
- 1.03
- Enterprise Value
- $10.34B